Latest CD4 Stories
WASHINGTON and RICHMOND, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
By Steve Sternberg WASHINGTON -- A new analysis of the best time to begin HIV treatment found that starting early sharply improves survival, doctors said Sunday.
A simple test given to HIV/AIDS patients in southern Africa could extend their lives by nearly a year and save health-care costs at the same time, according to a new study by researchers at the Stanford University School of Medicine and the Palo Alto Veterans Affairs Health Care System.
CAMBRIDGE, Mass., Aug.
Reducing stress can bolster the immune system in human immunodeficiency virus, or HIV-positive adults, U.S. researchers said. CD4+ T lymphocytes, or CD4 T cells, are the brains of the immune system, coordinating its activity when the body comes under attack.
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by treatment with zinc finger DNA-binding protein nucleases (ZFN(TM)).
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of data from a phase 1 dose escalation study evaluating the effects of IL-7 therapy on human lymphocytes in subjects with non-hematologic, non-lymphoid cancer refractory to standard therapy.
SEATTLE, June 18 /PRNewswire/ -- Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission.
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) reported Sunday they have discovered another mechanism used by the AIDS virus to attack cells.
Pipex Pharmaceuticals, Inc. (OTCBB: PPXP), a speci
- a meat pie that is usually eaten at Christmas in Quebec